-
1
-
-
0027517934
-
The pharmacology of α-adrenergic decongestants
-
Johnson DA, Hricik JG: The pharmacology of α-adrenergic decongestants. Pharmacotherapy 1993; 13:110S-115S.
-
(1993)
Pharmacotherapy
, vol.13
-
-
Johnson, D.A.1
Hricik, J.G.2
-
2
-
-
0027369881
-
Pharmacokinetics of oral decongestants
-
Kanfer I, Dowse R, Vuma V: Pharmacokinetics of oral decongestants. Pharmacotherapy 1993; 13:1165-1285.
-
(1993)
Pharmacotherapy
, vol.13
, pp. 1165-1285
-
-
Kanfer, I.1
Dowse, R.2
Vuma, V.3
-
3
-
-
0016429230
-
A comparison of plasma levels of L(+) pseudoephedrine after different formulations, and their relation to cardiovascular and subjective effects in man
-
Bye C, Hill HM, Hughes DTD, Peck AW: A comparison of plasma levels of L(+) pseudoephedrine after different formulations, and their relation to cardiovascular and subjective effects in man. Eur J Clin Pharmacol 1975; 8:47-53.
-
(1975)
Eur J Clin Pharmacol
, vol.8
, pp. 47-53
-
-
Bye, C.1
Hill, H.M.2
Hughes, D.T.D.3
Peck, A.W.4
-
4
-
-
0019457074
-
Sensitive assay for pseudoephedrine and its metabolite, norpseudoephedrine in plasma and urine using gas-liquid chromatography with electron-capture detection
-
Lo LY, Land G, Bye A: Sensitive assay for pseudoephedrine and its metabolite, norpseudoephedrine in plasma and urine using gas-liquid chromatography with electron-capture detection. J Chromatogr Biomed Appl 1981; 222:297-302.
-
(1981)
J Chromatogr Biomed Appl
, vol.222
, pp. 297-302
-
-
Lo, L.Y.1
Land, G.2
Bye, A.3
-
5
-
-
0026089407
-
The influence of diuretics in the excretion and metabolism of doping agents. VI. Pseudoephedrine
-
Delbeke FT, Debackere M: The influence of diuretics in the excretion and metabolism of doping agents. VI. Pseudoephedrine. Biopharm Drug Dispos 1991; 12:37-48.
-
(1991)
Biopharm Drug Dispos
, vol.12
, pp. 37-48
-
-
Delbeke, F.T.1
Debackere, M.2
-
6
-
-
0015359868
-
Enhanced pseudoephedrine absorption by concurrent administration of aluminum hydroxide gel in humans
-
Lucarotti RL, Colaizzi JL, Barry H III, Poust RI: Enhanced pseudoephedrine absorption by concurrent administration of aluminum hydroxide gel in humans. J Pharm Sci 1972; 61:903-905.
-
(1972)
J Pharm Sci
, vol.61
, pp. 903-905
-
-
Lucarotti, R.L.1
Colaizzi, J.L.2
Barry III, H.3
Poust, R.I.4
-
7
-
-
0018662307
-
Urinary excretion of chlorpheniramine and pseudoephedrine in humans
-
Lai CM, Stoll RG, Look ZM, Yacobi A: Urinary excretion of chlorpheniramine and pseudoephedrine in humans. J Pharm Sci 1979; 68:1243-1246.
-
(1979)
J Pharm Sci
, vol.68
, pp. 1243-1246
-
-
Lai, C.M.1
Stoll, R.G.2
Look, Z.M.3
Yacobi, A.4
-
8
-
-
0019189809
-
Renal excretion of pseudoephedrine
-
Brater DC, Kaojaren S, Benet LZ, Lin ET, Lockwood T, Morris, RC, et al: Renal excretion of pseudoephedrine. Clin Pharmacol Ther 1980; 28:690-694.
-
(1980)
Clin Pharmacol Ther
, vol.28
, pp. 690-694
-
-
Brater, D.C.1
Kaojaren, S.2
Benet, L.Z.3
Lin, E.T.4
Lockwood, T.5
Morris, R.C.6
-
9
-
-
0018731035
-
Comparison of GLC and high-pressure liquid chromatographic methods for analysis of urinary pseudoephedrine
-
Baaske DM, Lai C-M, Klein L, Look ZM, Yacobi A: Comparison of GLC and high-pressure liquid chromatographic methods for analysis of urinary pseudoephedrine. J Pharm Sci 1979; 68:1472.
-
(1979)
J Pharm Sci
, vol.68
, pp. 1472
-
-
Baaske, D.M.1
Lai, C.-M.2
Klein, L.3
Look, Z.M.4
Yacobi, A.5
-
10
-
-
0014980134
-
The influence of urinary pH on the half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma
-
Kuntzman RG, Tsai I, Brand L, Mark LC: The influence of urinary pH on the half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma. Clin Pharmacol Ther 1971; 12:62-67.
-
(1971)
Clin Pharmacol Ther
, vol.12
, pp. 62-67
-
-
Kuntzman, R.G.1
Tsai, I.2
Brand, L.3
Mark, L.C.4
-
11
-
-
0023932012
-
Influence of a standard meal on the absorption of a controlled release pseudoephedrine suspension
-
Graves DA, Wecher MT, Meyer MC, Straughn AB, Amsel PL, Hinsvark ON, et al: Influence of a standard meal on the absorption of a controlled release pseudoephedrine suspension. Biopharm Drug Dispos 1988; 9:267-272.
-
(1988)
Biopharm Drug Dispos
, vol.9
, pp. 267-272
-
-
Graves, D.A.1
Wecher, M.T.2
Meyer, M.C.3
Straughn, A.B.4
Amsel, P.L.5
Hinsvark, O.N.6
-
12
-
-
0023118299
-
Influence of a standard meal on the absorption of controlled-release pseudoephedrine capsules
-
Wecker MT, Graves DA, Amsel LP, Hinsvark ON: Influence of a standard meal on the absorption of controlled-release pseudoephedrine capsules. J Pharm Sci 1987; 76:29-31.
-
(1987)
J Pharm Sci
, vol.76
, pp. 29-31
-
-
Wecker, M.T.1
Graves, D.A.2
Amsel, L.P.3
Hinsvark, O.N.4
-
13
-
-
0021705467
-
Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products
-
Williams BO, Liao SHT, Lai AA, Arnold JD, Perkins JG, Blum MR, Findlay JW: Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products. Clin Pharm 1984; 3:638-643.
-
(1984)
Clin Pharm
, vol.3
, pp. 638-643
-
-
Williams, B.O.1
Liao, S.H.T.2
Lai, A.A.3
Arnold, J.D.4
Perkins, J.G.5
Blum, M.R.6
Findlay, J.W.7
-
14
-
-
0018241207
-
Dose tolerance and pharmacokinetic studies of L(+) pseudoephedrine capsules in man
-
Dickerson J, Perrier D, Mayersohn M, Bressler R: Dose tolerance and pharmacokinetic studies of L(+) pseudoephedrine capsules in man. Eur J Clin Pharmacol 1978; 14:253-259.
-
(1978)
Eur J Clin Pharmacol
, vol.14
, pp. 253-259
-
-
Dickerson, J.1
Perrier, D.2
Mayersohn, M.3
Bressler, R.4
-
15
-
-
77956935139
-
Pseudoephedrine hydrochloride
-
Florey K (ed.): New York: Academic Press
-
Benezra SA, McRae JW: Pseudoephedrine hydrochloride. In, Florey K (ed.): Analytical Profiles of Drug Substances. New York: Academic Press, 1979; 489-507.
-
(1979)
Analytical Profiles of Drug Substances
, pp. 489-507
-
-
Benezra, S.A.1
McRae, J.W.2
-
16
-
-
0021263892
-
Evaluation of the CNS properties of loratadine (SCH 29851), a potential nonsedating antihistamine
-
Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A: Evaluation of the CNS properties of loratadine (SCH 29851), a potential nonsedating antihistamine. Agents Actions 1984; 14:590-597.
-
(1984)
Agents Actions
, vol.14
, pp. 590-597
-
-
Barnett, A.1
Iorio, L.C.2
Kreutner, W.3
Tozzi, S.4
Ahn, H.S.5
Gulbenkian, A.6
-
17
-
-
0004021418
-
Comparison of efficacy and safety of SCH 29851, terfenadine and placebo in treatment of seasonal rhinitis
-
Bedard PM, Del Carpio J, Gutkowski A, Hebert J, Prevost M, Schulz J, et al: Comparison of efficacy and safety of SCH 29851, terfenadine and placebo in treatment of seasonal rhinitis (abstract). Ann Allergy 1985; 55:233.
-
(1985)
Ann Allergy
, vol.55
, pp. 233
-
-
Bedard, P.M.1
Del Carpio, J.2
Gutkowski, A.3
Hebert, J.4
Prevost, M.5
Schulz, J.6
-
19
-
-
0023212250
-
Safety and efficacy of loratadine (SCH 29851), a new nonsedating antihistamine in seasonal allergic rhinitis
-
Dockhorn RJ, Bergner A, Connell JR, Falliers CJ, Grabiec SV, Weiler JM, Shellenberger MK: Safety and efficacy of loratadine (SCH 29851), a new nonsedating antihistamine in seasonal allergic rhinitis. Ann Allergy 1987; 58:407-411.
-
(1987)
Ann Allergy
, vol.58
, pp. 407-411
-
-
Dockhorn, R.J.1
Bergner, A.2
Connell, J.R.3
Falliers, C.J.4
Grabiec, S.V.5
Weiler, J.M.6
Shellenberger, M.K.7
-
20
-
-
1842506126
-
Loratadine vs. astemizole: Onset of allergy symptoms relief
-
May
-
Kaminszczik I, Soto-Roman L, Kutwak A, Rodriguez L, Cataldo J, Ronaj H, Alliende HF: Loratadine vs. astemizole: onset of allergy symptoms relief (abstract). Presented at the XIIIth Congress of the European Academy of Allergy and Clinical Immunology, May 1986.
-
(1986)
XIIIth Congress of the European Academy of Allergy and Clinical Immunology
-
-
Kaminszczik, I.1
Soto-Roman, L.2
Kutwak, A.3
Rodriguez, L.4
Cataldo, J.5
Ronaj, H.6
Alliende, H.F.7
-
21
-
-
0023094591
-
Antiallergic activity of loratadine, a nonsedating antihistamine
-
Kreutner W, Chapman RW, Gulbenkian A, Siegel M: Antiallergic activity of loratadine, a nonsedating antihistamine. Allergy 1987; 42:57-63.
-
(1987)
Allergy
, vol.42
, pp. 57-63
-
-
Kreutner, W.1
Chapman, R.W.2
Gulbenkian, A.3
Siegel, M.4
-
22
-
-
0024367950
-
Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis
-
Del Carpio I, Kabbash L, Turenne Y, Prevost M, Hebert J, Bedard PM, et al: Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1989; 84:741-746.
-
(1989)
J Allergy Clin Immunol
, vol.84
, pp. 741-746
-
-
Del Carpio, I.1
Kabbash, L.2
Turenne, Y.3
Prevost, M.4
Hebert, J.5
Bedard, P.M.6
-
23
-
-
0023091016
-
Loratadine (SCH 29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of allergic rhinitis
-
Bruttmann G, Pedrali P: Loratadine (SCH 29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of allergic rhinitis. J Int Med Res 1987; 15:63-70.
-
(1987)
J Int Med Res
, vol.15
, pp. 63-70
-
-
Bruttmann, G.1
Pedrali, P.2
-
26
-
-
0023544915
-
Pharmacokinetics and dose proportionality of loratadine
-
Hilbert J, Radwanski E, Weglein R, Luc V, Perentesis G, Symchowicz S, Zampaglione N: Pharmacokinetics and dose proportionality of loratadine. J Clin Pharmacol 1987; 27:694-698.
-
(1987)
J Clin Pharmacol
, vol.27
, pp. 694-698
-
-
Hilbert, J.1
Radwanski, E.2
Weglein, R.3
Luc, V.4
Perentesis, G.5
Symchowicz, S.6
Zampaglione, N.7
-
28
-
-
0028593587
-
Loratadine, a reappraisal of its pharmacological properties and therapeutics in allergic disorders
-
Haria M, Fitton A, Peters DH: Loratadine, a reappraisal of its pharmacological properties and therapeutics in allergic disorders. Drugs 1994; 48:617-637.
-
(1994)
Drugs
, vol.48
, pp. 617-637
-
-
Haria, M.1
Fitton, A.2
Peters, D.H.3
-
29
-
-
0024556615
-
Loratadine: A preliminary review of its pharmacodynamic properties and therapeutic efficacy
-
Clissold S, Sorkin E, Goa K: Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989; 37:42-57.
-
(1989)
Drugs
, vol.37
, pp. 42-57
-
-
Clissold, S.1
Sorkin, E.2
Goa, K.3
-
30
-
-
0026729605
-
New data on the safety of loratadine
-
Van Cauwenberge P: New data on the safety of loratadine. Drug Invest 1992; 4:283-291.
-
(1992)
Drug Invest
, vol.4
, pp. 283-291
-
-
Van Cauwenberge, P.1
-
31
-
-
0019969141
-
A double-blind controlled evaluation of Actified and its individual constituents in allergic rhinitis
-
Connell JT, Williams BO, Allen S, Cato A, Perkins JG: A double-blind controlled evaluation of Actified and its individual constituents in allergic rhinitis. J Int Med Res 1982; 10:341-347.
-
(1982)
J Int Med Res
, vol.10
, pp. 341-347
-
-
Connell, J.T.1
Williams, B.O.2
Allen, S.3
Cato, A.4
Perkins, J.G.5
-
32
-
-
0019513561
-
An evaluation of tripolidine and pseudoephedrine in the treatment of allergic rhinitis
-
Diamond L, Gerson K, Cato A, Peace K, Perkins JG: An evaluation of tripolidine and pseudoephedrine in the treatment of allergic rhinitis. Ann Allergy 1981; 47:87-91.
-
(1981)
Ann Allergy
, vol.47
, pp. 87-91
-
-
Diamond, L.1
Gerson, K.2
Cato, A.3
Peace, K.4
Perkins, J.G.5
-
33
-
-
0018909921
-
Controlled comparison of a new antihistamine-decongestant combination to its individual components
-
Falliers CJ, Redding MA: Controlled comparison of a new antihistamine-decongestant combination to its individual components. Ann Allergy 1980; 45:75-80.
-
(1980)
Ann Allergy
, vol.45
, pp. 75-80
-
-
Falliers, C.J.1
Redding, M.A.2
-
34
-
-
0016442138
-
A double-blind crossover trial of pseudoephedrine and tripolidine alone and in combination for the treatment of allergic rhinitis
-
Empey DW, Dye C, Hodder M, Hughes DTD: A double-blind crossover trial of pseudoephedrine and tripolidine alone and in combination for the treatment of allergic rhinitis. Ann Allergy 1975; 34:41-46.
-
(1975)
Ann Allergy
, vol.34
, pp. 41-46
-
-
Empey, D.W.1
Dye, C.2
Hodder, M.3
Hughes, D.T.D.4
-
35
-
-
0018356454
-
A novel method to assess antihistamine and decongestant efficacy
-
Connell JT: A novel method to assess antihistamine and decongestant efficacy. Ann Allergy 1979; 42:278-285.
-
(1979)
Ann Allergy
, vol.42
, pp. 278-285
-
-
Connell, J.T.1
-
36
-
-
0014082674
-
Combination therapy in hay fever and allergic rhinitis
-
Thomson WAR, Garland J (eds): Combination therapy in hay fever and allergic rhinitis. Practitioner 1967; 198:713-716.
-
(1967)
Practitioner
, vol.198
, pp. 713-716
-
-
Thomson, W.A.R.1
Garland, J.2
-
38
-
-
1842506125
-
Loratadine and pseudoephedrine sulfate: A double-blind, placebo-controlled comparison of a combination tablet (SCH 434) and its individual components in seasonal allergic rhinitis
-
Hebert J, Bedard PM, Del Carpio J, Drouin M, Gutkowski A, Kabbash LG, et al: Loratadine and pseudoephedrine sulfate: a double-blind, placebo-controlled comparison of a combination tablet (SCH 434) and its individual components in seasonal allergic rhinitis. Am J Rhinol 1988; 2:71-75.
-
(1988)
Am J Rhinol
, vol.2
, pp. 71-75
-
-
Hebert, J.1
Bedard, P.M.2
Del Carpio, J.3
Drouin, M.4
Gutkowski, A.5
Kabbash, L.G.6
-
39
-
-
0028321468
-
Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis
-
Prevost M, Turenne Y, Moote DW, Mazza J, Clermont A, PetitClerc C, Danzig R: Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Clin Ther 1994; 16:50-56.
-
(1994)
Clin Ther
, vol.16
, pp. 50-56
-
-
Prevost, M.1
Turenne, Y.2
Moote, D.W.3
Mazza, J.4
Clermont, A.5
PetitClerc, C.6
Danzig, R.7
-
40
-
-
0028260312
-
Sensitive gas-liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine in human plasma using a nitrogen-phosphorus detector
-
Johnson R, Christensen J, Lin C-C: Sensitive gas-liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine in human plasma using a nitrogen-phosphorus detector. J Chromatogr 1994; 657:125-131.
-
(1994)
J Chromatogr
, vol.657
, pp. 125-131
-
-
Johnson, R.1
Christensen, J.2
Lin, C.-C.3
-
43
-
-
78651147390
-
Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single dose of drug
-
Wagner JG, Nelson E: Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single dose of drug. J Pharm Sci 1964; 53:1392-1394.
-
(1964)
J Pharm Sci
, vol.53
, pp. 1392-1394
-
-
Wagner, J.G.1
Nelson, E.2
-
44
-
-
0023615056
-
A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
-
Schuirmann DJ: A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15:657-680.
-
(1987)
J Pharmacokinet Biopharm
, vol.15
, pp. 657-680
-
-
Schuirmann, D.J.1
-
46
-
-
0017383466
-
Influence of food and diet on gastrointestinal drug absorption: A review
-
Welling PG: Influence of food and diet on gastrointestinal drug absorption: a review. J Pharmacokinet Biopharm 1977; 5:291-334.
-
(1977)
J Pharmacokinet Biopharm
, vol.5
, pp. 291-334
-
-
Welling, P.G.1
-
48
-
-
0028966473
-
In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product
-
Hwang SS, Gorsline J, Louie J, Dye D, Guinta D, Hamel L: In vitro and in vivo evaluation of a once-daily controlled-release pseudoephedrine product. J Clin Pharmacol 1995; 35:259-267.
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 259-267
-
-
Hwang, S.S.1
Gorsline, J.2
Louie, J.3
Dye, D.4
Guinta, D.5
Hamel, L.6
-
49
-
-
0025940081
-
Effect of food on bioavailability of pseudoephedrine and brompheniramine administered from a gastrointestinal therapeutic system
-
Chao ST, Prather D, Pinson D, Coen P, Pruitt B, Knowles M, Place V: Effect of food on bioavailability of pseudoephedrine and brompheniramine administered from a gastrointestinal therapeutic system. J Pharm Sci 1991; 80:432-435.
-
(1991)
J Pharm Sci
, vol.80
, pp. 432-435
-
-
Chao, S.T.1
Prather, D.2
Pinson, D.3
Coen, P.4
Pruitt, B.5
Knowles, M.6
Place, V.7
-
51
-
-
0017686998
-
Enhancement of hydralazine bioavailability by food
-
Melander A, Danielson K, Hanson A, Rudell B, Schersten B, Thulin T, Wahlin E: Enhancement of hydralazine bioavailability by food. Clin Pharmacol Ther 1977; 22:104-107.
-
(1977)
Clin Pharmacol Ther
, vol.22
, pp. 104-107
-
-
Melander, A.1
Danielson, K.2
Hanson, A.3
Rudell, B.4
Schersten, B.5
Thulin, T.6
Wahlin, E.7
|